- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 150 Pages
Global
From €4681EUR$4,850USD£4,016GBP
- Report
- March 2024
- 181 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 182 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 186 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 183 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 194 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 196 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 293 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 294 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 384 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 360 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- April 2024
- 193 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- September 2023
- 160 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- June 2023
- 150 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- May 2023
- 180 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- November 2023
- 147 Pages
Global
From €2412EUR$2,499USD£2,069GBP
The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more